Massimiliano Palombi

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice.

Rethinking the feasibility and safety of venetoclaxobinutuzumab in chronic lymphocytic leukemia: nontraditional factors may play a role in clinical practice.

Journal: Haematologica

Published: March 20, 2025

Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.

Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 11, 2017

Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.

Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: April 20, 2016

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?

Journal: Blood research

Published: May 10, 2015

Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy.

Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy.

Journal: Journal of chemotherapy (Florence, Italy)

Published: August 03, 2013

Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.

Journal: Blood research

Published: July 27, 2013

Managing myelodysplastic syndromes in very old patients: a teaching case report.

Managing myelodysplastic syndromes in very old patients: a teaching case report.

Journal: Clinical interventions in aging

Published: April 24, 2013

Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin.

Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin.

Journal: The Korean journal of hematology

Published: January 16, 2013

Dysgeusia in patients with hematological malignancies: a reminder for hematologist.

Dysgeusia in patients with hematological malignancies: a reminder for hematologist.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Published: January 03, 2013

IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome.

IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome.

Journal: Asian journal of transfusion science

Published: September 19, 2012

Authors' reply.

Authors' reply.

Journal: Indian journal of palliative care

Published: February 21, 2012

Transfusions at home in patients with myelodysplastic syndromes.

Transfusions at home in patients with myelodysplastic syndromes.

Journal: Leukemia research

Published: September 29, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026